We are live on
!
Find out more
NIM
NEOS Investment Management Portfolio holdings
AUM
$27.1B
1-Year Est. Return
57.21%
This Fund
S&P 500
This Quarter
Est. Return
+4.83%
1 Year Est. Return
+57.21%
3 Year Est. Return
+163.05%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.25B
AUM Growth
+$935M
(+28%)
Cap. Flow
+$872M
Cap. Flow
% of AUM
20.54%
Top 10 Holdings %
Top 10 Hldgs %
37.69%
Holding
613
New
34
Increased
490
Reduced
55
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Russell 2000 ETF
VTWO
|
+$78.8M |
| 2 |
Apple
AAPL
|
+$66.5M |
| 3 |
NVIDIA
NVDA
|
+$55.9M |
| 4 |
Microsoft
MSFT
|
+$53.9M |
| 5 |
Amazon
AMZN
|
+$37.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
|
+$17.1M |
| 2 |
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
|
+$17.1M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$3.06M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
+$2.53M |
| 5 |
Insulet
PODD
|
+$1.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.68% |
| 2 | Consumer Discretionary | 10.52% |
| 3 | Healthcare | 10.01% |
| 4 | Communication Services | 9.79% |
| 5 | Financials | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Pool Corp
POOL
$6.19B
| – | – |
-537
| Closed | -$202K |
|
602
Ferrari
RACE
$71.8B
| – | – |
-469
| Closed | -$220K |
|
|
603
Ultragenyx Pharmaceutical
RARE
$1.29B
| – | – |
-45,599
| Closed | -$2.53M |
|
|
604
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.74B
| – | – |
-395,438
| Closed | -$17.1M |
|
|
605
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.71B
| – | – |
-668,356
| Closed | -$17.1M |
|
|
SLN
606
Silence Therapeutics
SLN
$787M
| – | – |
-51,712
| Closed | -$940K |
|
|
SLNO
607
DELISTED
Soleno Therapeutics
SLNO
| – | – |
-14,033
| Closed | -$709K |
|
608
Tenaya Therapeutics
TNYA
$150M
| – | – |
-169,127
| Closed | -$326K |
|
|
VERV
609
DELISTED
Verve Therapeutics
VERV
| – | – |
-95,029
| Closed | -$460K |
|
610
Skye Bioscience
SKYE
$9.12M
| – | – |
-6,859
| Closed | -$215K |
|
|
SUM
611
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| – | – |
-78,474
| Closed | -$3.06M |
|
|
CTLT
612
DELISTED
CATALENT, INC.
CTLT
| – | – |
-4,837
| Closed | -$293K |
|
|
MRO
613
DELISTED
Marathon Oil Corporation
MRO
| – | – |
-27,401
| Closed | -$730K |
|
Similar funds
RG
LP
RCMU
SC
SO
NEOS Investment Management's Q4 2024 Portfolio in Review
As of Q4 2024, NEOS Investment Management held 613 positions worth $4.25B, up 28% from $3.31B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
NEOS Investment Management deployed $872M of net new capital in Q4 2024, opening 34 new positions and adding to 490 existing holdings. Its largest new stake was Palantir: 258,157 shares worth $19.5M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Insulet, an estimated $1.27M trimmed.
- NEOS Investment Management's largest Q4 2024 buy was Palantir: 258,157 shares worth $19.5M.
- NEOS Investment Management added most to Vanguard Russell 2000 ETF in Q4 2024, an estimated $78.8M increase.
- NEOS Investment Management's biggest Q4 2024 reduction was Insulet, cutting an estimated $1.27M.
- NEOS Investment Management fully exited State Street SPDR Bloomberg Short Term High Yield Bond ETF in Q4 2024, selling an estimated $17.1M.
- NEOS Investment Management's ten largest holdings make up 38% of its $4.25B portfolio in Q4 2024.
- NEOS Investment Management opened 34 new positions and closed 25 in Q4 2024.
- NEOS Investment Management's portfolio value rose 28% quarter-over-quarter to $4.25B.
Based on NEOS Investment Management's 13F filing for Q4 2024, filed 12 Feb 2025.